Aceso Life Science Group (SEHK:474) Income Statement Analysis 2004-2025

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Metric	2023	2024	LTM
Total Revenue	HK$11M	HK$195M	HK$166M
Cost of Sales	HK$111M	HK$105M	HK$74M
Gross Profit	HK$-100M	HK$90M	HK$61M
Research And Development Expenses	-	-	-
Selling, General And Administrative Expenses	HK$124M	HK$114M	-
Other Expenses	HK$-7M	-	HK$114M
Operating Profit	HK$-224M	HK$-24M	HK$-53M
Net Interest Income	HK$-108M	HK$-114M	HK$-36M
Other Non-operating Income	HK$-491M	HK$-889M	HK$-352M
Total Non-operating Income	HK$-0.599B	HK$-1.003B	HK$-0.388B
EBT	HK$-0.823B	HK$-1.027B	HK$-0.441B
Income Tax Expense	HK$-14M	HK$-10M	HK$-5M
Net Income	HK$-462M	HK$-895M	HK$-372M

Earnings Per Share (Basic)	HK$-0.064	HK$-0.12	HK$-0.057
Earnings Per Share (Diluted)	HK$-0.064	HK$-0.12	HK$-0.057
Weighted-Average Shares Outstanding (Basic)	HK$7.274B	HK$7.197B	HK$14.507B
Weighted-Average Shares Outstanding (Diluted)	HK$7.274B	HK$7.197B	HK$14.507B

EBITDA	HK$-220M	HK$-860M	HK$-210M
Depreciation And Amortization	HK$50M	HK$43M	HK$24M
EBIT	HK$-680M	HK$-903M	HK$-234M

Aceso Life Science Group Income Statement

Revenue And Expenses Breakdown